Progyny Inc (NASDAQ: PGNY) on Tuesday, soared 0.31% from the previous trading day ,before settling in for the closing price of $35.84. Within the past 52 weeks, PGNY’s price has moved between $29.44 and $44.95.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 61.75% over the past five years. The company achieved an average annual earnings per share of 12.21%. With a float of $82.99 million, this company’s outstanding shares have now reached $95.73 million.
Let’s look at the performance matrix of the company that is accounted for 566 employees.
Progyny Inc (PGNY) Insider and Institutional Ownership
Observing investor behavior towards Health Information Services industry stocks is more important than anything else. The insider ownership of Progyny Inc is 14.00%, while institutional ownership is 87.04%. The most recent insider transaction that took place on Nov 23 ’24, was worth 11,258. In this transaction Director of this company sold 200 shares at a rate of $56.29, taking the stock ownership to the 580,656 shares. Before that another transaction happened on Apr 01 ’24, when Company’s CHIEF FINANCIAL OFFICER sold 11,165 for $37.62, making the entire transaction worth $419,979. This insider now owns 50,119 shares in total.
Progyny Inc (PGNY) Latest Financial update
As on 12/30/2023, Multinational firm has announced its last quarter scores, in which it reported $0.13 earnings per share (EPS) for the period topping the consensus outlook (set at $0.11) by $0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.21% per share during the next fiscal year.
Progyny Inc (NASDAQ: PGNY) Trading Performance Indicators
Progyny Inc (PGNY) is currently performing well based on its current performance indicators. A quick ratio of 3.44 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.19. Likewise, its price to free cash flow for the trailing twelve months is 18.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.62, a number that is poised to hit 0.13 in the next quarter and is forecasted to reach 0.99 in one year’s time.
Technical Analysis of Progyny Inc (PGNY)
Progyny Inc (NASDAQ: PGNY) saw its 5-day average volume 0.57 million, a negative change from its year-to-date volume of 0.8 million. As of the previous 9 days, the stock’s Stochastic %D was 15.72%. Additionally, its Average True Range was 1.14.
During the past 100 days, Progyny Inc’s (PGNY) raw stochastic average was set at 44.87%, which indicates a significant increase from 21.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 25.66% in the past 14 days, which was lower than the 42.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $37.58, while its 200-day Moving Average is $36.39. Nevertheless, the first resistance level for the watch stands at $36.34 in the near term. At $36.74, the stock is likely to face the second major resistance level. The third major resistance level sits at $37.11. If the price goes on to break the first support level at $35.57, it is likely to go to the next support level at $35.20. The third support level lies at $34.80 if the price breaches the second support level.
Progyny Inc (NASDAQ: PGNY) Key Stats
Market capitalization of the company is 3.47 billion based on 96,499K outstanding shares. Right now, sales total 1,089 M and income totals 62,040 K. The company made 269,940 K in profit during its latest quarter, and 13,470 K in sales during its previous quarter.
